e-SPACE Cardio-Renal-Metabolic 2023
Published: 25 March 2023
1h 6m 3sPart 1 | Session 7 Plenary session 4 – Guidelines implementation for acutely ill patients
58m 41sPart 1 | Session 8 Plenary session 5 – Mineralocorticoids antagonists in CRM disease
59m 5sPart 1 | Session 10 Plenary session 6 – Diuretics: old drugs, new data, new approaches
59m 17sPart 2 | Session 5 Plenary session 9 – Managing “metals”
1h 2m 16sPart 2 | Session 7 Plenary session 10 – Management of diabetes with kidney disease
1h 3m 10sPart 2 | Session 8 Plenary session 11 – Managing frail and elderly patients
1h 1m 47sPart 2 | Session 9 Plenary session 12 – Managing end-stage disease: focus on QoL
58m 8sPart 1 | Session 1 Plenary session 1 – HFpEF Andrew JS Coats, Giuseppe Rosano, Eberhard Standl, María José Soler, Stefan Anker
51m 57sPart 1 | Session 2 Satellite symposium – SGLT2 inhibitors in cardio-renal-metabolic patients – the perfect fit? (Supported by an educational grant from the Boehringer Ingelheim & Lilly Alliance) Stefan Anker, Paola Fioretto, Michel Jadoul
56m 38sPart 1 | Session 3 Plenary session 2 – SGLT2 updates Andrew JS Coats, Hiddo Lambers Heerspink, Antonio Ceriello, Gianluigi Savarese, Christoph Wanner
31m 38sPart 1 | Session 4 Meet the expert – Management of heart failure in real world clinical practice – insights from the REWOLUTION HF surveys Ewa Jankowska, Andrew JS Coats
e-SPACE Cardio-Renal-Metabolic 2023 was the third edition of the annual global online conference that explores how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.
Course leadership Prof Stefan Anker (Berlin, DE), Dr Javed Butler (Texas, US), Prof Antonio Ceriello (Milan, IT), Prof Tara I Chang (California, US), Prof Ian de Boer (Washington, US), Prof Peter Rossing (Copenhagen, DK) and Prof Shelley Zieroth (Winnipeg, CA) lead an interactive programme of plenary sessions, meet the expert, case discussions and satellite symposium sessions focusing on the patient journey.
For the first time, e-SPACE Cardio-Renal-Metabolic 2023 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
- Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
- Describe the complexity and interlink between the three conditions
- Discuss existing guidelines and best approaches for screening patients
- Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
- Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
- General Practitioners (GPs)
- HF Specialists
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Luc Van Gaal
Head of the Department of Endocrinology, Diabetology, and Metabolism
Prof Luc Van Gaal is Head of the Department of Endocrinology, Diabetology, and Metabolism at University of Antwerp, Antwerp, BE.
In 1983, he obtained a specialist degree in internal medicine and afterward in endocrinology and metabolism.
His main clinical and research interests are related to obesity, type 2 diabetes, and lipid metabolism.
Prof Van Gaal is a board member of the Belgian Association for the Study of Obesity (BASO) and Past-President of the Belgian Diabetic Society.
Prof Wolfram Doehner is a Cardiologist and Professor of Interdisciplinary Stroke Research at Charité – Universitätsmedizin Berlin, Berlin, DE.
He was a member of the ESC programme committee (2014-2020) and was Chairman (2018-2020) of the ESC Council on Stroke.
Prof Doehner's research focus is the peripheral aspect, and particularly, the skeletal muscle structure and metabolism in stroke patients.
Distinguished Scholar in Cardiovascular Science
Dr Milton Packer was born to Polish immigrants in 1951 and raised in Philadelphia, US. Prior to studying medicine, he was politically active in the 1960s. In his words: “The focus of my upbringing was education, but the major guiding principle in my childhood years (and throughout my entire life) was an uncompromising sense of justice. I was always imbued with the need to strive for and defend the truth.” He began his career in cardiology during a pivotal time for the field, just as interventional cardiology and
Carel le Roux
Head of Pathology
Prof Carel le Roux is Head of Pathology at University College Dublin, Dublin, IE.
He graduated from medical school in Pretoria South Africa, completed his Senior House Officer training at Barts and The London Hospital, his SpR training in metabolic medicine at the Hammersmith Hospitals and his PhD at Imperial College London.
Working within the Diabetes Complications Research Centre and the Section of Surgery and Surgical Specialities, the focus of Prof le Roux's research is primarily concerned with increased mortality and morbidity associated with obesity and diabetes.
Tammy Lyn Kindel
Dr Tammy Lyn Kindel is an Associate Professor at Medical College of Wisconsin, Wisconsin, US.
She received her medical training at the Ohio State University and completed general surgery residency at Northwestern Memorial Hospital / Feinberg School of Medicine in Chicago.
Dr Kindel's passion is the science and clinical practice of bariatric surgery for both adolescents and adults.
Dr Ildiko Lingvay is an Endocrinologist and Professor in the Department of Internal Medicine at UT Southwestern Medical Center, Texas, US.
Dr Lingvay earned her medical degree with honors at the University of Medicine and Pharmacy in Bucharest.
She specialises in clinical research in the fields of obesity, diabetes, and metabolic complications. Her research interests include metabolic syndrome, obesity, and diabetes mellitus.